3 ways outsourcing can unlock Africa’s pharmaceutical industry
Pharmaceutical outsourcing is a key strategy that could drive Africa's pharmaceutical growth and performance.
Bevin Likuyani
Bevin Likuyani is a pharmacist with a Master of Pharmacy in Pharmacoepidemiology and Pharmacovigilance and an MBA from the School of Business, University of Nairobi. He is a Certified Supply Chain Professional (CSCP) from the American (Association of Supply Chain Management) the founder of Pharvers, a pharma supply chain consulting company.
bevin@africanpharmaceuticalreview.com
Counterfeit Medicines : 3 Ways Africa Can Win The Fight (II)
Counterfeit Medicines are a pervasive global challenge with Africa showing huge vulnerabilities that make it an easy prey for those involved.
How To Improve Pharma Through Africa Pooled Procurement Mechanism
Africa Pooled Procurement Mechanism is a strategy poised to help improve affordability and accessibility of life saving medical products.
New Nation Has Officially Ratified The African Medicines Agency Treaty
A win for African Medicines Agency as yet another country signs the treaty. It is expected that this Agency will drive the improvement of Africa's pharma sector
NAFDAC boss: How local production is the answer to high cost of medicines
National Agency for Food and Drug Administration and Control (NAFDAC), is working with pharmaceutical companies to reduce high cost of medicines in Nigeria.
How to improve feasibility of local pharma manufacturing in Africa
Through local pharma manufacturing, Africa could unlock the full potential of Africa's pharmaceutical sector. How can it be done in a sustainable manner?
10 Important Medical Product Recalls In The African Market So Far (2024)
Medical product recalls is a great strategy in post-market surveillance in ensuring a market only has quality, safe and efficacious health products.
WHO Maturity Levels 3 and 4 : How To Attract More African Countries
Many African National Medicines Regulatory Authorities (NRAs) aspire to reach WHO Maturity levels 3 and 4 but struggle to do so. Financing is a major hindrance.
How To Limit Patient Harm By Reducing Medication Errors
A core facet of patient safety and pharmacovigilance that tends to be relegated to an afterthought is medication errors.
Why Multinational Pharma Companies Are Withdrawing Operations In Africa.
When GSK’s CEO Emma Walmsley took over office from Andrew Witty in 2017, her strategy was clear; to create a more competitive operating model for the company’s business in emerging markets. A move, at the time, expected to affect 29…
